8-K
filed June 24, 2025, 7:59 PM ET
ticker HYPD
CIK 0001682639
other material
confidence high
sentiment neutral
materiality 0.85
Eyenovia raises $50M to acquire HYPE tokens, shifts to crypto treasury strategy; appoints new CIO
HYPERION DEFI, INC.
- $50M PIPE for HYPE tokens; warrants could raise ~$150M more if exercised at $3.25/share.
- Hyunsu Jung appointed CIO and board member; three directors resigned per investor agreement.
- Loan amended: maturity extended to July 2028, interest rate cut to 8% (half PIK), interest-only through Jan 2027.
- Company expects to rename to Hyperion DeFi and change ticker to HYPD.
- Gen-2 Optejet device still in development; FDA registration anticipated by September 2025.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Sean Ianchulev resigned as Director at HYPERION DEFI, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
On June 17, 2025, Sean Ianchulev, M.D., Charles Mather IV (Chair) and Ram Palanki, Pharm. D., resigned from the Board and their respective positions on the committees of the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Hyunsu Jung was appointed as Chief Investment Officer at HYPERION DEFI, INC..
- Action
- appointed
- Role
- Chief Investment Officer
Exact text from the filing
On June 17, 2025, the Board of Directors (the “Board”) of the Company appointed Hyunsu Jung to the position of Chief Investment Officer and to serve on the Board, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ram Palanki resigned as Director at HYPERION DEFI, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
On June 17, 2025, Sean Ianchulev, M.D., Charles Mather IV (Chair) and Ram Palanki, Pharm. D., resigned from the Board and their respective positions on the committees of the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Charles Mather IV resigned as Chair at HYPERION DEFI, INC..
- Action
- resigned
- Role
- Chair
Exact text from the filing
On June 17, 2025, Sean Ianchulev, M.D., Charles Mather IV (Chair) and Ram Palanki, Pharm. D., resigned from the Board and their respective positions on the committees of the Board.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
HYPERION DEFI, INC.: Filed Certificate of Designation for Series A Preferred Stock, establishing terms of a new series of preferred stock (effective 2025-06-20).
- Change
- charter amendment
- Effective
- 2025-06-20
Exact text from the filing
On June 20, 2025, the Company filed a Certificate of Designation of Preferences, Rights and Limitations with the Secretary of State of the State of Delaware to provide for the designation of shares of the Series A Preferred Stock (the "Certificate of Designation"), which became effective upon filing.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.